Dosing: How Each Drug Is Taken Both are once-weekly subcutaneous injections that escalate gradually to reduce side effects
FDA staff's own briefing document, posted publicly ahead of the meeting as part of the docket, proposes that TB-500 (free base) and TB-500 acetate not be added to the list, citing incomplete physicochemical characterization, a lack of evidence of effectiveness for wound healing (including an in-vitro fibroblast study in which TB-500 reportedly did not induce wound healing), and insufficient nonclinical and clinical safety data
Keeping tabs on side effects is crucial, and thus far, retatrutides profile resembles other GLP-1 drugs
Thank you to the Tri Valley team
Potency correlated better with -helicity in our computational model, although we have found that the energy barrier between the two mentioned conformations is low in our most potent analogues and the flexibility of the N-terminus is highlighted by the dynamics simulations